Skip to main content

Osteopontin is a proximal effector of leptin-mediated non-alcoholic steatohepatitis (NASH) fibrosis.

Publication ,  Journal Article
Coombes, JD; Choi, SS; Swiderska-Syn, M; Manka, P; Reid, DT; Palma, E; Briones-Orta, MA; Xie, G; Younis, R; Kitamura, N; Della Peruta, M ...
Published in: Biochim Biophys Acta
January 2016

INTRODUCTION: Liver fibrosis develops when hepatic stellate cells (HSC) are activated into collagen-producing myofibroblasts. In non-alcoholic steatohepatitis (NASH), the adipokine leptin is upregulated, and promotes liver fibrosis by directly activating HSC via the hedgehog pathway. We reported that hedgehog-regulated osteopontin (OPN) plays a key role in promoting liver fibrosis. Herein, we evaluated if OPN mediates leptin-profibrogenic effects in NASH. METHODS: Leptin-deficient (ob/ob) and wild-type (WT) mice were fed control or methionine-choline deficient (MCD) diet. Liver tissues were assessed by Sirius-red, OPN and αSMA IHC, and qRT-PCR for fibrogenic genes. In vitro, HSC with stable OPN (or control) knockdown were treated with recombinant (r)leptin and OPN-neutralizing or sham-aptamers. HSC response to OPN loss was assessed by wound healing assay. OPN-aptamers were also added to precision-cut liver slices (PCLS), and administered to MCD-fed WT (leptin-intact) mice to determine if OPN neutralization abrogated fibrogenesis. RESULTS: MCD-fed WT mice developed NASH-fibrosis, upregulated OPN, and accumulated αSMA+ cells. Conversely, MCD-fed ob/ob mice developed less fibrosis and accumulated fewer αSMA+ and OPN+ cells. In vitro, leptin-treated HSC upregulated OPN, αSMA, collagen 1α1 and TGFβ mRNA by nearly 3-fold, but this effect was blunted by OPN loss. Inhibition of PI3K and transduction of dominant negative-Akt abrogated leptin-mediated OPN induction, while constitutive active-Akt upregulated OPN. Finally, OPN neutralization reduced leptin-mediated fibrogenesis in both PCLS and MCD-fed mice. CONCLUSION: OPN overexpression in NASH enhances leptin-mediated fibrogenesis via PI3K/Akt. OPN neutralization significantly reduces NASH fibrosis, reinforcing the potential utility of targeting OPN in the treatment of patients with advanced NASH.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Biochim Biophys Acta

DOI

ISSN

0006-3002

Publication Date

January 2016

Volume

1862

Issue

1

Start / End Page

135 / 144

Location

Netherlands

Related Subject Headings

  • Up-Regulation
  • Signal Transduction
  • Rats, Sprague-Dawley
  • Proto-Oncogene Proteins c-akt
  • Phosphatidylinositol 3-Kinases
  • Osteopontin
  • Non-alcoholic Fatty Liver Disease
  • Mice, Inbred C57BL
  • Male
  • Liver Cirrhosis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Coombes, J. D., Choi, S. S., Swiderska-Syn, M., Manka, P., Reid, D. T., Palma, E., … Syn, W.-K. (2016). Osteopontin is a proximal effector of leptin-mediated non-alcoholic steatohepatitis (NASH) fibrosis. Biochim Biophys Acta, 1862(1), 135–144. https://doi.org/10.1016/j.bbadis.2015.10.028
Coombes, Jason D., Steve S. Choi, Marzena Swiderska-Syn, Paul Manka, Danielle T. Reid, Elena Palma, Marco A. Briones-Orta, et al. “Osteopontin is a proximal effector of leptin-mediated non-alcoholic steatohepatitis (NASH) fibrosis.Biochim Biophys Acta 1862, no. 1 (January 2016): 135–44. https://doi.org/10.1016/j.bbadis.2015.10.028.
Coombes JD, Choi SS, Swiderska-Syn M, Manka P, Reid DT, Palma E, et al. Osteopontin is a proximal effector of leptin-mediated non-alcoholic steatohepatitis (NASH) fibrosis. Biochim Biophys Acta. 2016 Jan;1862(1):135–44.
Coombes, Jason D., et al. “Osteopontin is a proximal effector of leptin-mediated non-alcoholic steatohepatitis (NASH) fibrosis.Biochim Biophys Acta, vol. 1862, no. 1, Jan. 2016, pp. 135–44. Pubmed, doi:10.1016/j.bbadis.2015.10.028.
Coombes JD, Choi SS, Swiderska-Syn M, Manka P, Reid DT, Palma E, Briones-Orta MA, Xie G, Younis R, Kitamura N, Della Peruta M, Bitencourt S, Dollé L, Oo YH, Mi Z, Kuo PC, Williams R, Chokshi S, Canbay A, Claridge LC, Eksteen B, Diehl AM, Syn W-K. Osteopontin is a proximal effector of leptin-mediated non-alcoholic steatohepatitis (NASH) fibrosis. Biochim Biophys Acta. 2016 Jan;1862(1):135–144.

Published In

Biochim Biophys Acta

DOI

ISSN

0006-3002

Publication Date

January 2016

Volume

1862

Issue

1

Start / End Page

135 / 144

Location

Netherlands

Related Subject Headings

  • Up-Regulation
  • Signal Transduction
  • Rats, Sprague-Dawley
  • Proto-Oncogene Proteins c-akt
  • Phosphatidylinositol 3-Kinases
  • Osteopontin
  • Non-alcoholic Fatty Liver Disease
  • Mice, Inbred C57BL
  • Male
  • Liver Cirrhosis